RFC
INO icon

Russell Frank Company’s Inovio Pharmaceuticals INO Stock Holding History

Russell Frank Company’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$1.45M Buy
+13,887
New +$1.07M ﹤0.01% 2008
2014
Q2 		– Sell
-3,944
Closed -$460K – 2807
2014
Q1 		$460K Buy
+3,944
New +$566K ﹤0.01% 2411

Other funds holding INO

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SIP
Stoneridge Investment Partners Radnor, Pennsylvania $138M AUM 7.66% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Russell Frank Company's INO Position: Q1 2016 in Review

Russell Frank Company opened a new position in Inovio Pharmaceuticals (INO) in Q1 2016: 13,887 shares worth $1.45M. The stake represents ﹤0.01% of the portfolio and ranks #2008 among its holdings. This is a return to the name: Russell Frank Company previously reported a position in INO as recently as Q1 2014.

Russell Frank Company first reported a position in INO in Q1 2014 and has held it in 2 quarters since. 115 funds tracked by Wall St. Rank hold INO as of Q1 2016.

  • Russell Frank Company held 13,887 shares of Inovio Pharmaceuticals worth $1.45M as of Q1 2016.
  • Inovio Pharmaceuticals was a new Russell Frank Company position in Q1 2016.
  • Inovio Pharmaceuticals made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2008 holding.
  • Russell Frank Company first reported a position in Inovio Pharmaceuticals in Q1 2014 and has held it in 2 quarters since.
  • 115 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.